Physician profile
Jim Maxka
NPI 1932427762
$2,010.67
in general payments reported to CMS, 2019-2025
16 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.87 · 2022: $687 · 2023: $480 · 2024: $519 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $720.37 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $333.22 | 2024-2025 | Nuzyra |
| Abbvie INC. | $272.58 | 2022-2025 | |
| Medtronic, INC. | $129.92 | 2024-2025 | Inceptiv |
| Organogenesis INC. | $100.71 | 2021-2025 | Nushield |
| Averitas Pharma INC. | $94.94 | 2023-2025 | Qutenza |
| Ibsa Pharma INC. | $58.59 | 2023 | Tirosint, Licart |
| Paragon 28, INC. | $55.94 | 2023 | Mtp |
| Vaporox, INC. | $52.00 | 2023 | Vht-200 Wound Treatment System |
| Bioventus LLC | $35.06 | 2023 | |
| Mimedx Group, INC. | $34.29 | 2024 | |
| Stryker Corporation | $31.21 | 2023 | Citrefix |
| Convatec INC. | $28.82 | 2023-2024 | |
| Kci USA, INC. | $26.87 | 2023 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Alexion Pharmaceuticals, INC. | $23.19 | 2024 | Strensiq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $12.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jim Maxka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.